Cargando…

Intravenous fosfomycin therapy in critically ill patients infected with colistin-resistant enterobacteriacae

Detalles Bibliográficos
Autores principales:	Mukherjee, DN, Agarwal, L, Nayyar, I
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4471504/ http://dx.doi.org/10.1186/cc14199

Ejemplares similares

Carbapenem-resistant enterobacteriacae: a challenge for early detection and infection control
por: Fankhauser, C, et al.
Publicado: (2011)

Emergence of isolates that are intrinsically resistant to colistin in critically ill patients: are we selecting them out?
por: Sivakumar, MN, et al.
Publicado: (2015)

Efficacy and safety of once daily dosing of colistin to critically ill patients
por: Skiada, A, et al.
Publicado: (2010)

Pharmacokinetics of inhaled colistin in critically ill patients with ventilator-associated tracheobronchitis
por: Athanassa, Z, et al.
Publicado: (2012)

Inhaled colistin for the treatment of ventilator-associated tracheobronchitis in critically ill patients
por: Athanassa, Z, et al.
Publicado: (2011)

1242. Efficacy and Safety of Intravenous Fosfomycin for the Treatment of Multi-resistant Gram Negative Infections
por: Abdallah, Tasneem, et al.
Publicado: (2021)

Efficacy and pharmacokinetics of intravenous paracetamol in the critically ill patient
por: Samson, AD, et al.
Publicado: (2009)

Intravenous paracetamol (Prodafalgan) causes hypotension in critically ill patients
por: Hersch, M, et al.
Publicado: (2004)

Synergistic activity of fosfomycin–meropenem and fosfomycin–colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
por: Bakthavatchalam, Yamuna Devi, et al.
Publicado: (2020)

Obstetric delivery in mechanically ventilated critically ill pregnant women
por: Lapinsky, SE, et al.
Publicado: (2015)

In vitro antibacterial effect of fosfomycin combination therapy against colistin-resistant Klebsiella pneumoniae
por: Yu, Wei, et al.
Publicado: (2018)

Colistin monotherapy versus therapy combination
por: Charra, B, et al.
Publicado: (2010)

Effect of increasing intravenous glucose load in the presence of normoglycemia on outcome and metabolism in critically ill rabbits
por: Derde, S, et al.
Publicado: (2009)

Parenteral colistin for the treatment of severe infections by multidrug-resistant Gram-negative bacteria
por: Grion, C, et al.
Publicado: (2013)

Antimicrobial Susceptibility among Colistin, Sulbactam, and Fosfomycin and a Synergism Study of Colistin in Combination with Sulbactam or Fosfomycin against Clinical Isolates of Carbapenem-Resistant Acinetobacter baumannii
por: Leelasupasri, Sombat, et al.
Publicado: (2018)

IN VITRO TO IN VIVO: COMBATING MULTIDRUG-RESISTANT ENTEROBACTERIACAE IN THE AGE OF COVID-19
por: WALKER, CHRISTOPHER B, et al.
Publicado: (2022)

Colistin monotherapy versus combination of colistin with a β-lactam or rifampicin for the treatment of serious infections in the ICU due to multidrug-resistant Gram-negative bacteria
por: Tsimogianni, A, et al.
Publicado: (2006)

Effect of intravenous immunoglobulin in critically ill adult patients with sepsis: a meta-analysis
por: Turgeon, A, et al.
Publicado: (2006)

Prevalence of colonisation with third generation cephalosporin-resistant enterobacteriacae (3GCREB) on admission - a cross-sectional study in 6 university hospitals
por: Rohde, AM, et al.
Publicado: (2015)

Point and trend accuracy of continuous glucose monitoring using intravenous microdialysis in critically ill patients
por: Leopold, JH, et al.
Publicado: (2015)

Coexistence of Fosfomycin and Colistin Resistance in Klebsiella pneumoniae: Whole-Genome Shotgun Sequencing
por: Veeraraghavan, Balaji, et al.
Publicado: (2016)

Efficacy and safety of colistin in the treatment of infections in the ICU caused by multidrug-resistant Gram-negative organisms
por: Pavleas, J, et al.
Publicado: (2006)

Cortisol metabolism in critical illness: effects of intensive insulin therapy
por: Vanhorebeek, I, et al.
Publicado: (2005)

Efficacy of an intravenous colistin regimen in ventilator-associated pneumonia and bacteraemia due to multiresistant Gram-negative bacteria: preliminary results
por: Frantzeskaki, F, et al.
Publicado: (2006)

Evaluation of Intravenous Fosfomycin Disodium Dosing Regimens in Critically Ill Patients for Treatment of Carbapenem-Resistant Enterobacterales Infections Using Monte Carlo Simulation
por: Leelawattanachai, Pannee, et al.
Publicado: (2020)

Procalcitonin as a marker of infection in critically ill patients
por: Koukiasa, P, et al.
Publicado: (2004)

Clinical Use of Intravenous Fosfomycin in Critical Care Patients in Taiwan
por: Chen, Tzu-Ting, et al.
Publicado: (2023)

Risk factors for the development of carbapenem-resistant Klebsiella pneumoniae infections in critically ill patients
por: Vardakas, KZ, et al.
Publicado: (2010)

Population pharmacokinetics of intravenous colistin sulfate and dosage optimization in critically ill patients
por: Xie, Yue-liang, et al.
Publicado: (2022)

Fungal colonization and infection in critically ill patients
por: Lorente, L, et al.
Publicado: (2005)

Colonization and infection by MRSA in critically ill patients
por: Lorente, L, et al.
Publicado: (2007)

Cytokines associated with insulin resistance in critically ill patients
por: Omar, S, et al.
Publicado: (2007)

Early treatment with intravenous immunoglobulins in patients with critical illness polyneuropathy: a randomized controlled, double-blinded study
por: Brunner, R, et al.
Publicado: (2012)

0716. Does intravenous iron induce oxydative stress in critically ill patients? A comparison with healthy volunteers
por: Lasocki, S, et al.
Publicado: (2014)

Comparison of multidrug-resistant Acinetobacter and non-Acinetobacter infections in terms of outcome in critically ill patients
por: Madaan, A, et al.
Publicado: (2014)

Comparison of multidrug-resistant acinetobacter and non-acinetobacter infections in terms of outcome in critically ill patients
por: Madaan, A, et al.
Publicado: (2015)

Usefulness of quantitative analysis of beta-D-glucan in empirical therapy for systematic Candida infection in critically ill patients
por: Kano, I, et al.
Publicado: (2005)

Anidulafungin compared with fluconazole therapy in critically ill patients
por: Kett, DH, et al.
Publicado: (2010)

Recombinant human erythropoietin therapy in critically ill patients
por: Georgopoulos, D, et al.
Publicado: (2005)

Severe hypophosphatemia in the critically ill: are we replacing enough?
por: Millwood Hargrave, J, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_5ie28qqhkqm69j0va8a97f915l